levallorphan has been researched along with nalbuphine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dykstra, LA | 1 |
Haertzen, CA | 1 |
Hein, DW; Stephens, KR; Woods, JH; Young, AM | 1 |
Aksu, F; Fujimoto, JM; Holmes, BB | 1 |
Morgan, D; Picker, MJ | 1 |
1 trial(s) available for levallorphan and nalbuphine
Article | Year |
---|---|
Subjective effects of narcotic antagonists.
Topics: Analysis of Variance; Codeine; Cyclazocine; Dextropropoxyphene; Dose-Response Relationship, Drug; Emotions; Humans; Levallorphan; Lysergic Acid Diethylamide; Morphine Dependence; Nalbuphine; Nalorphine; Narcotic Antagonists; Pentazocine; Placebos; Substance Withdrawal Syndrome; Surveys and Questionnaires | 1973 |
4 other study(ies) available for levallorphan and nalbuphine
Article | Year |
---|---|
Butorphanol, levallorphan, nalbuphine and nalorphine as antagonists in the squirrel monkey.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Butorphanol; Dose-Response Relationship, Drug; Levallorphan; Male; Methadone; Morphinans; Nalbuphine; Nalorphine; Naltrexone; Pyrrolidines; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu; Saimiri | 1990 |
Reinforcing and discriminative stimulus properties of mixed agonist-antagonist opioids.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Buprenorphine; Butorphanol; Cycloparaffins; Discrimination Learning; Female; Levallorphan; Macaca mulatta; Male; Morphinans; Nalbuphine; Narcotic Antagonists; Narcotics; Pyridines; Pyrrolidines; Reinforcement, Psychology; Tetrahydronaphthalenes | 1984 |
Opioid antagonists: indirect antagonism of morphine analgesia by spinal dynorphin A.
Topics: Analgesia; Animals; Dose-Response Relationship, Drug; Dynorphins; Injections, Intraventricular; Injections, Spinal; Levallorphan; Male; Mice; Mice, Inbred ICR; Morphine; Nalbuphine; Naltrexone; Nociceptors; Spinal Cord | 1993 |
The mu opioid irreversible antagonist beta-funaltrexamine differentiates the discriminative stimulus effects of opioids with high and low efficacy at the mu opioid receptor.
Topics: Animals; Buprenorphine; Butorphanol; Columbidae; Discrimination Learning; Female; Fentanyl; Levallorphan; Methadone; Morphine; Nalbuphine; Nalorphine; Naltrexone; Narcotic Antagonists; Receptors, Opioid, mu | 1998 |